drugset / Trial / NCT07284693
Phenolic Complex k110-42 Therapy on Cognitive Functions in Down Children
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study is to evaluate the efficacy of phenolic complex k110-42 on cognitive function of children with Down syndrome
Timeline
- Start
- 2026-01
- Primary completion
- 2026-07
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Phenolic complex k110-42 | Unknown | 900 mg/kg | Oral |